Pharmafile Logo
Pharmafocus logo
Advanced Search

Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

February 3, 2023 Business Services

London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …
News
Press release

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease

February 3, 2023 Business Services

MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …
News
Press release

Phlo raises £10m to spearhead digital transformation in pharmacy sector

February 3, 2023 Business Services

[Glasgow, Scotland]  Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio.   …
News
Press release

Novartis announces cut to multiple drug research programmes in 2022 full-year report

February 2, 2023 Business Services

Novartis, a Swiss pharmaceutical company, has announced in its 2022 full-year report that it is cutting several of their programmes, …
News
shaking-hands-gb7ac17374_1920

Sherlock Biosciences acquires Sense Biodetection to advance CRISPR-based diagnostics

February 2, 2023 Business Services

US-based biotech company Sherlock Biosciences has acquired UK-based developer of rapid molecular diagnostics Sense Biodetection.   The acquisition will integrate …
News

PureTech to Present at the SVB Securities Global Biopharma Conference

February 1, 2023 Business Services

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) (“PureTech” or the “Company”), a clinical-stage biotherapeutics company dedicated to changing the treatment …
News
Press release

Ellipses Pharma announces FDA approval of IND application for EP0042 for patients with acute myeloid leukaemia

February 1, 2023 Business Services

Ellipses Pharma (“Ellipses”), a global drug development company focused on accelerating the development of cancer medicines and treatments through an …
News
Press release

ViCentra bolsters leadership team with the appointment of Leo Toole as Chief Financial Officer and expands European commercialization

February 1, 2023 Business Services

February 1, Utrecht, The Netherlands   ViCentra B.V., the company behind Kaleido, one of the world’s smallest, lightest and most …
News
Press release

Germo Gericke, MD

February 1, 2023 Business Services

Dr. Gericke brings extensive experience in the research and development of radioligand therapies Appointment coincides with launch of Ariceum International …
Appointment

Sequana Medical announces grant of additional DSR® patent in United States

February 1, 2023 Business Services

Ghent, Belgium – 1 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medic
News
Press release

Neuraxpharm announces closing of acquisition of established products from Sanofi

February 1, 2023 Business Services

Düsseldorf and Barcelona – February 1, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …
News
Press release

Dr Jean-Michel Cosséry

February 1, 2023 Business Services

Jean-Michel brings 25 years of experience in the international pharmaceutical and biotech industries both in an executive and non-executive capacity …
Appointment

Rare and Orphan disease expert Terebellum to launch incisive Specialty Pharmacy development bulletins, Specialty Pharmaceutical Pulse™

January 31, 2023 Business Services

Global healthcare and business consulting services provider Terebellum is launching a brand-new monthly Specialty Pharmaceutical Pulse™ insights bulletin in the …
News
Press release

Dr. Lin Römer

January 31, 2023 Business Services

Munich, 31 January 2023 – Insempra, a biology-powered company enabling businesses to make superior products in partnership with nature, today …
Appointment

Vertex and CRISPR Therapeutics Announce MHRA Marketing Authorisation Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa-cel

January 30, 2023 Business Services

London, UK and ZUG, Switzerland, January 27, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (NASDAQ: CRSP) today announced that …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025